跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Drixine - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Drixine
Approved
STANDARD
Drixine
Famar Montreal Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b627421b8ca8b316
Company
Famar Montreal Inc.
Type
Standard
Approval Details
Approval Id
b627421b8ca8b316
Drug Approval Philippines Name
Drixine
Product Name
Drixine
Registration Number
DR-XY46699
Brand Name
Drixine
Generic Name
Oxymetazoline Hydrochloride
Dosage Form
Nasal Spray
Dosage Strength
500mcg/mL (0.05%)
Manufacturer
Famar Montreal Inc.
Importer
Bayer Philippines, Inc.
Distributor
Bayer Philippines, Inc.
Issuance Date
24 May 2023
Expiry Date
12 September 2026
Pharmacologic Category
Nasal Decongestant
Classification
Over-The-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b627421b8ca8b316
Type
Standard
Back to Philippines FDA Approvals